Abstract
Checkpoint kinase 1 (CHK1) is an attractive therapeutic target for cancer treatment as CHK1 is a key mediator in the DNA damage-induced checkpoint network. The structure-based drug design approach was used to achieve this objective which includes the 3D-QSAR studies, where a series of selenophene derivatives to investigate the structural requirements of their inhibitory activity against CHK1 was used for the development of the model. The generated model was precise with r2 = 0.95 and q2 = 0.68. Furthermore, the study involves the use of structure-based virtual screening of specs database and induced fit docking studies to retrieve potential CHK1 inhibitors.
Original language | English (US) |
---|---|
Pages (from-to) | 2271-2277 |
Number of pages | 7 |
Journal | Current Science |
Volume | 109 |
Issue number | 12 |
DOIs | |
State | Published - 2015 |
Externally published | Yes |
Keywords
- Checkpoint kinase 1
- Induced fit docking
- Toxicity prediction
- Virtual screening
ASJC Scopus subject areas
- General